US Patent Issued to Luxembourg Institute of Health (LIH) on March 17 for "Selective ACKR3 modulators and uses thereof" (Luxembourger, Bangladeshi Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,578,343, issued on March 17, was assigned to Luxembourg Institute of Health (LIH) (Luxembourg).

"Selective ACKR3 modulators and uses thereof" was invented by Max Marc Roger Meyrath (Leudelange, Luxembourg), Martyna Szpakowska (Luxembourg) and Andy Chevigne (Saint Leger, Bangladesh).

According to the abstract* released by the U.S. Patent & Trademark Office: "The application discloses selective ACKR3 modulating peptides comprising amino acid sequence FGGX1MRRX2 (SEQ ID NO: 1), wherein X1 is F or W; X2 is K, V or F; and wherein the peptides have a length of at most 15 amino acids; fusion proteins comprising the peptides as taught herein; nucleic acids encoding the peptides as taught he...